Sign up to save your podcasts
Or
Share Episode 14 - Vascepa, Vyondys 53, & Padcev
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 14 - Vascepa, Vyondys 53, & Padcev
In episode 14 we discuss approval of Padcev for urothelial cancer, Vyondys 53 for Duchenne Muscular dystrophy, added indications for Xtandi and Xeljanz XR, and approval of Vascepa to reduce the risk of cardiovascular events. Have a great holiday season everyone!
View all episodes
By Ian Parnigoni PharmD.In episode 14 we discuss approval of Padcev for urothelial cancer, Vyondys 53 for Duchenne Muscular dystrophy, added indications for Xtandi and Xeljanz XR, and approval of Vascepa to reduce the risk of cardiovascular events. Have a great holiday season everyone!